NASDAQ · PHVS
Pharvaris N.V financials
$31.73−0.56%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — |
| Operating income | -$199.2M | -$151.6M | -$107.1M | -$93.0M | -$61.6M |
| Net income | -$206.6M | -$139.5M | -$111.6M | -$81.9M | -$48.6M |
| Net margin | — | — | — | — | — |
| Diluted EPS | $-3.48 | $-2.58 | $-2.91 | $-2.43 | $-1.59 |
| EBITDA | -$198.8M | -$151.3M | -$106.8M | -$92.9M | -$61.5M |
| Operating cash flow | -$160.8M | -$125.0M | -$102.9M | -$72.0M | -$50.7M |
| Free cash flow | -$161.0M | -$125.6M | -$103.0M | -$72.2M | -$50.9M |
| Diluted shares | 59.2M | 54.0M | 38.4M | 33.6M | 30.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $342.2M | $292.1M | $432.5M | $173.6M | $238.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $353.7M | $303.2M | $440.7M | $179.9M | $241.2M |
| Total liabilities | $35.4M | $24.6M | $16.2M | $19.8M | $8.1M |
| Shareholders' equity | $318.3M | $278.6M | $424.5M | $160.1M | $233.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology